News - Pharmaceuticals
WINNERS CROWNED: Health Industry Hub Catalysts for Change Awards 2025

A huge congratulations to the WINNERS of the Health Industry Hub Catalysts for Change Awards 2025!
The Health Industry Hub Awards is a celebration and recognition of the remarkable individuals and organisations that inspire us to challenge the status quo and embark on a purposeful journey to reimagine healthcare across the entire patient journey.
The Awards ceremony buzzed with an electric mix of anticipation, glamour, and celebration. The atmosphere was charged as guests arrived in elegant attire, cameras flashed, and laughter mingled with the hum of conversation. Every detail, from the soft lighting to the upbeat music, built excitement, while finalists sat poised between nerves and hope. When the spotlight hit the stage and envelopes were opened, the room held its breath before erupting into applause and cheers.
A heartfelt thanks to guest speakers Martin Bowles joined in conversation with Kieran Schneemann, and Dr Geoff Lester. Martin and Kieran led a candid and bold discussion on the complex and volatile health policy landscape, with guests remarking that “it’s refreshing to hear” such an open exchange.
Geoff’s brave and deeply human reflection on what it means to stand on both sides of care, as both clinician and patient, truly moved the audience. His words were a powerful reminder that true advocacy begins with listening, and that empathy is the bridge that connects knowledge to compassion, and expertise to lived experience.
Many left the Health Industry Hub Awards ceremony feeling inspired and hopeful that together, we can reimagine healthcare not just for patients, but with them. Congratulations to all the amazing WINNERS and FINALISTS!
✨WINNERS
A huge congratulations to all the WINNERS
Advancing Health Policy
- Medicines Australia

Advocacy Champion
- Rare Cancers Australia & Icon Group

Digital & AI Champion
- Philips

Excellence in Collaboration
- InGeNA & Pathology Technology Australia

Excellence in Innovation
- Novo Nordisk

Inspirational leadership
- Organon

Medical Excellence
- Amgen & A/Professor Shaun Fleming

Pulse of Industry
- Baxter, Sanofi


People & Culture Excellence
- Novartis

Sustainability Champion
- Cardinal Health

Unmasking Election 2025
- Australian Patient Advocacy Alliance (APAA) & Crohn’s & Colitis Australia (CCA)
- AstraZeneca & Private Cancer Physicians of Australia (PCPA)


Visionary Leadership
- Vantive

Excellence in Communications
Corporate Communications Individual of the Year
- Rebecca Mojsin, Boehringer Ingelheim

Corporate Communications Team of the Year
- Eli Lilly, Pfizer


Government Relations & Policy Team of the Year
- Medtronic

Government Relations & Policy Individual of the Year
- Anna Karelas, Vertex

NGO of the Year
- Hearts4heart

PR & Advocacy Agency Team of the Year
- Cube

PR & Advocacy Individual of the Year
- Kirsten Bruce – VIVA! Communications

Interview of the Year
- AstraZeneca

✨We celebrated courage, dedication, and excellence. Let us carry this momentum forward as we push beyond the boundaries, collaborate more purposefully, and continue shaping the future of healthcare for our families, our communities and the future generations.





News - MedTech & Diagnostics
Hearts4heart takes aim at health insurers leaving patients to pay the price
Persistent advocacy by patient groups has prompted the Medical Services Advisory Committee (MSAC) to review the funding gaps for pulsed […]
MoreNews - MedTech & Diagnostics
Queensland first: Private hospitals deploy Abbott’s PFA in atrial fibrillation
More Australians living with atrial fibrillation (AF) are gaining access to one of the latest advances in heart-rhythm treatment, with […]
MoreNews - Pharmaceuticals
Five years of HTA reform talk, now comes the $47 billion question
Medicines Australia has put a $47 billion price tag on what it says Australia must invest to improve equitable access […]
MoreNews - Pharmaceuticals
New MFN deals raise the stakes for Australia’s delayed HTA reform
Four months after the US Trump administration concluded what was expected to be the final tranche of drug-pricing agreements with […]
More